Cynthia Cetani
Compliance Officer en INDIVIOR PLC .
Fortuna: 7 M $ al 29/02/2024
Perfil
Currently, Cynthia Cetani is Chief Compliance & Integrity Officer at Indivior PLC.
She previously held the position of Head-Compliance Operations & Group Integrity at Novartis AG and Chief Compliance Officer for Novartis Pharmaceuticals Corp.
(a subsidiary of Novartis AG).
She received a graduate degree from Rider University.
Participaciones conocidas en empresas públicas
Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
---|---|---|---|---|
INDIVIOR PLC
0.14% | 01/03/2024 | 187 810 ( 0.14% ) | 4 M $ | 29/02/2024 |
INDIVIOR PLC
0.09% | 14/03/2024 | 121 737 ( 0.09% ) | 3 M $ | 29/02/2024 |
Cargos activos de Cynthia Cetani
Empresas | Cargo | Inicio |
---|---|---|
INDIVIOR PLC | Compliance Officer | 01/10/2018 |
Antiguos cargos conocidos de Cynthia Cetani.
Empresas | Cargo | Fin |
---|---|---|
NOVARTIS AG | Compliance Officer | - |
Novartis Pharmaceuticals Corp.
Novartis Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Novartis Pharmaceuticals Corp. develops, manufactures, and markets prescription drugs. It manufactures and markets prescription drugs used to treat a number of diseases and conditions including cardiovascular, dermatological, central nervous system, bone disease, cancer, organ transplantation, psychiatry, infectious disease, and respiratory. The company was founded in 1996 and is headquartered in East Hanover, NJ. | Compliance Officer | - |
Formación de Cynthia Cetani.
Rider University | Graduate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
Empresas cotizadas | 2 |
---|---|
INDIVIOR PLC | Health Technology |
NOVARTIS AG | Health Technology |
Empresas privadas | 1 |
---|---|
Novartis Pharmaceuticals Corp.
Novartis Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Novartis Pharmaceuticals Corp. develops, manufactures, and markets prescription drugs. It manufactures and markets prescription drugs used to treat a number of diseases and conditions including cardiovascular, dermatological, central nervous system, bone disease, cancer, organ transplantation, psychiatry, infectious disease, and respiratory. The company was founded in 1996 and is headquartered in East Hanover, NJ. | Health Technology |